KALYANKJIL:NSEKalyan Jewellers India Ltd. Analysis
Data as of 2026-06-12 - not real-time
₹335.45
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Kalyan Jewellers delivered a blockbuster FY26, with consolidated revenue soaring **43% YoY to INR 35,743 crore** and net profit jumping **~89% to INR 1,351 crore**. The Q4 results reinforced this trend, showing a **66% revenue surge** and a **118% profit surge** versus the prior year, underpinning a strong top‑line momentum. However, the share price of **₹335.45** sits well below its 20‑day, 50‑day and 200‑day SMAs (₹350.76, ₹387.07, ₹443.07), the 14‑day RSI is at **36.5** (near‑oversold), and the MACD line remains **bearish**, indicating short‑term price weakness and a need for a bounce above the **₹327.05 support** before upside can be realized.
On the valuation front, the DCF‑derived fair value of **₹267.7** is markedly lower than the current market price, suggesting the stock is **overvalued** relative to intrinsic fundamentals. The company carries a **high debt‑to‑equity of ~97%**, negative free cash flow, and a modest **0.45% dividend yield** with an 11% payout, raising concerns about cash‑flow sustainability. Moreover, the recent MSCI index exclusion adds a layer of **regulatory/benchmark risk**. While growth is impressive, the combination of elevated leverage, premium multiples, and bearish technicals warrants a cautious stance.
On the valuation front, the DCF‑derived fair value of **₹267.7** is markedly lower than the current market price, suggesting the stock is **overvalued** relative to intrinsic fundamentals. The company carries a **high debt‑to‑equity of ~97%**, negative free cash flow, and a modest **0.45% dividend yield** with an 11% payout, raising concerns about cash‑flow sustainability. Moreover, the recent MSCI index exclusion adds a layer of **regulatory/benchmark risk**. While growth is impressive, the combination of elevated leverage, premium multiples, and bearish technicals warrants a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below all major SMAs indicating bearish momentum
- Support at ₹327.05 with decreasing volume
- Recent earnings beat but limited upside without a technical breakout
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Robust FY26 revenue and profit growth
- High leverage and negative free cash flow
- Overvaluation relative to DCF fair value
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained top‑line expansion in luxury jewellery market
- Debt reduction will be critical for valuation convergence
- Potential upside if MSCI exclusion is reversed and market sentiment improves
Key Metrics & Analysis
Financial Health
Revenue Growth66.90%
Profit Margin3.78%
P/E Ratio26.3
ROE24.31%
ROA7.21%
Debt/Equity96.97
P/B Ratio5.5
Op. Cash Flow₹13.2B
Free Cash Flow₹-5156782592
Technical Analysis
TrendBearish
RSI36.5
Support₹327.05
Resistance₹374.25
MA 20₹350.76
MA 50₹387.07
MA 200₹443.07
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71
Valuation
Fair Value₹267.72
Target Price₹664.44
Upside/Downside98.08%
GradeOvervalued
TypeBlend
Dividend Yield0.45%
Risk Assessment
Beta0.82
Volatility46.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.